Taligen Acquired by Alexion
Congratulations to the team at Taligen Therapeutics, Inc. who announced yesterday that they have been acquired by Alexion Pharmaceuticals [ALXN-G]. The Taligen transaction represents the first liquidity event in Colorado Fund I. You can read more about the transaction in Alexion’s press release.

No Comments